Realignment of leadership team improves upon customer and operational excellence in delivering persistent value to clients
INDIANAPOLIS — January 31, 2023 — TRIMEDX―an industry-leading, independent clinical asset management company delivering comprehensive clinical engineering services, clinical asset informatics, and medical device cybersecurity―announced new hires and promotions in a recent realignment of its leadership to improve upon customer & operational excellence and to ensure positioning for future growth.
TRIMEDX is well-positioned to best deliver on its commitments to clients and associates in working toward achieving its vision of unlocking the full potential of clinical assets for hospitals and health systems. The company’s comprehensive and integrated solutions deliver persistent value to clients by helping providers plan, standardize, and optimize their clinical assets in an environment of ever-increasing complexity and demand.
Kristi McDermott has been promoted to chief operating officer. McDermott has been with TRIMEDX since 2018 after the company acquired Aramark Healthcare Technologies and has served as chief commercial officer and president of clinical engineering during that time. She has been in the healthcare industry for almost 30 years and in the healthcare technologies industry for 13 years. McDermott earned a Bachelor of Science degree from Iowa State University and a master’s in business administration from Maryville University in St. Louis.
Rob Moorey has been promoted to president of clinical engineering. Moorey has been with TRIMEDX for over 9 years and has served as senior vice president of customer delivery and division vice president during that time. Before joining TRIMEDX, he spent eight years working for Aramark Healthcare Technologies in various leadership roles and began his career as a United States Air Force Biomedical Equipment Technician, stationed at Andrews Air Force Base outside Washington, D.C. Moorey earned his bachelor’s and master’s degree in Healthcare Administration from Wayland Baptist University in Plainview, Texas.
Jim McCoy has joined TRIMEDX as president of clinical asset management. He will lead the company’s clinical asset management and informatics solution that provides clients opportunities for financial and operational improvement within their clinical asset install base. McCoy comes to TRIMEDX from GE Healthcare after 26 years where he served in various roles of leadership including comprehensive services executive and asset management consultant. McCoy earned an associate degree in biomedical engineering technology from University of Alabama at Birmingham, a bachelor’s degree in management human resources from Trevecca Nazarene University, and a master’s in international business administration from American InterContinental University.
Tom Cooper has joined TRIMEDX as vice president of enterprise customer solutions. Cooper is responsible for initiating, maintaining, and expanding relationships with strategically aligned clients, including key national accounts. He has over 25 years of experience in the healthcare industry where he held numerous leadership positions in operations, service sales, and national accounts. Most recently, Cooper was the market vice president for GE Healthcare’s portfolio of products for the states of Tennessee, Mississippi, and Louisiana. He earned a bachelor’s degree in industrial engineering from Purdue University and a master’s in business administration from Saint Louis University.
TRIMEDX is an industry-leading, independent clinical asset management company in the United States delivering comprehensive clinical engineering services, clinical asset informatics, and medical device cybersecurity. We help healthcare providers transform their clinical assets into strategic tools, driving reductions in operational expenses, optimizing clinical asset capital spend, maximizing resources for patient care, and delivering improved safety and protection. TRIMEDX was built by providers, for providers, and leverages a history of expert clinical engineering with data on 92% of all active medical device models.